Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • AVIA Announces Nationwide Launch of its Digital Health Marketplace

    Jan 20, 2023, 09:37 AM by
    AVIA just announced the launch of AVIA Marketplace, a vendor selection platform available for free. It provides a one-stop shop for hospital and health systems executives to research and select digital health solutions for their transformation journey.
    Full story
  • NVIDIA Highlights AI, Large Language Model Advances in Life Sciences

    Jan 20, 2023, 01:00 AM by User Not Found
    Bio-IT World | NVIDIA is the only semiconductor manufacturer to ever present at the J.P. Morgan Healthcare Conference, said Harlan Sur, the firm’s semiconductor analyst in his introduction of Kimberly Powell, NVIDIA’s VP of healthcare. This year—NVIDIA’s fourth year presenting at the conference—Powell emphasized why NVIDIA is a crucial part of the healthcare ecosystem.
    Full story
  • Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina

    Jan 19, 2023, 10:14 AM by
    Verana Health Study Using Curated Real-World Data to Replicate Phase III Ophthalmology Clinical Trial Published in OSLI Retina
    Full story
  • CureSearch to lead impact study on cost, treatment benefits of molecular testing for childhood cancer patients

    Jan 19, 2023, 10:14 AM by
    CureSearch for Children's Cancer is collaborating with Children's Oncology Group (COG), Labcorp Drug Development, Pfizer, UTHealth Houston School of Public Health, and Thermo Fisher Scientific on a new study to examine the economic and treatment benefits of molecular testing for childhood cancer patients.
    Full story
  • Orbita Launches Solution to Transform Healthcare Website Search Functionality

    Jan 19, 2023, 10:12 AM by
    Orbita, a leading provider of intelligent virtual assistants and workflow automation for healthcare, launched a new solution set to transform the healthcare website experience. Orbita Blaze uses conversational AI and advanced search technology to interpret and address patients’ requests promptly and with precision, so they access the information and care they need.
    Full story
  • Digestion Speed The Latest Clue In Quest Against Obesity

    Jan 19, 2023, 01:00 AM by User Not Found
    Bio-IT World | The time it takes food to travel from the mouth to the rectum may change the metabolism of microbes in the gut. That’s one of the intriguing possibilities raised by a stool energy density study on overweight Danes recently completed by researchers at the University of Copenhagen, reports Henrik Roager, associate professor in the department of nutrition, exercise and sports.
    Full story
  • VisualDx Awarded Grant to Advance Global Health and Diagnostic Accuracy in Underserved Regions

    Jan 18, 2023, 09:32 AM by
    The Bill & Melinda Gates Foundation awarded VisualDx a new grant to develop diagnostic tools for surveillance, detection, and triage of Neglected Tropical Diseases (NTDs) and other rare infectious diseases in India and Nigeria. This project comes on the heels of similar public health collaborations with HHS and the state of Vermont. It also marks the second Gates Foundation grant VisualDx has received, following a successful 2020 project in Botswana to provide an offline version of its clinical decision support tool for users in remote areas.
    Full story
  • Netherlands Cancer Institute (NKI) Selects Proscia To Drive Personalized Diagnosis

    Jan 18, 2023, 09:32 AM by
    Transition to modern digital pathology will improve patient care and enable new research breakthroughs
    Full story
  • Biopharma PEG Provides PEG Products Used As ADC Linker

    Jan 18, 2023, 09:31 AM by
    About Biopharma PEG As a leading manufacturer of PEG derivatives, Biochempeg is dedicated to being your most reliable partner to provide a chemical synthesis and high-quality PEG linkers. We are committed to promoting the progress of your ADC discovery and development projects. Contact us Biopharma PEG Scientific Inc. Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA TEL: 1-857-366-6766 Fax: 617-206-9595 Email: sales@biochempeg.com Website:https://www.biochempeg.com/
    Full story
  • Greenphire Appoints Owen Newman as CFO to Accelerate Company Growth

    Jan 17, 2023, 10:39 AM by
    Greenphire Appoints Owen Newman as CFO to Accelerate Company Growth. The 25-year veteran brings deep expertise in financial management as the need for site and patient-centric solutions for clinical trials increases.
    Full story
  • Tune Therapeutics Welcomes Noted Industry Leader Dr. John McHutchison to Board of Directors

    Jan 17, 2023, 10:28 AM by
    Tune Therapeutics, a biotechnology company pioneering the creation of genetic tuning (epigenomic editing) therapies, today announced the addition of John McHutchison AO, MD – former CEO at Assembly Biosciences, Inc., and CSO at Gilead Sciences, Inc. – to its board of directors.
    Full story
  • Three Ion Exchange Resins Released: Mixed Bed Resins, Chelating Resins, and Adsorbent Resins

    Jan 17, 2023, 10:25 AM by
    Full story
  • Integrated Development Services for Health Care Products

    Jan 17, 2023, 10:24 AM by
    Full story
  • OncoDxRx’s One-Of-A-Kind Liquid Biopsy PGA Platform Backed by Comprehensive Cancer Pathway Profiling

    Jan 17, 2023, 10:23 AM by
    OncoDxRx’s one-of-a-kind liquid biopsy PGA platform is a breakthrough backed by comprehensive profiling of cancer pathways and anti-cancer drugs.
    Full story
  • Global Federated Machine Learning Model Detects Glioblastoma Borders

    Jan 17, 2023, 01:00 AM by User Not Found
    Bio-IT World | In a paper published late last year in Nature Communications, researchers from Penn Medicine and Intel Labs report on what they call the largest to-date global federated learning effort to develop an accurate and generalizable machine learning model for detecting glioblastoma borders. The work has important implications both clinically and as a model for future large, federated learning projects.
    Full story
  • Why Are Carbon Nanomaterials Favored by Researchers?

    Jan 16, 2023, 10:25 AM by
    Full story
  • CD Formulation Offers 16 types of Food Ingredients as Raw Materials to Manufacture Health Care Products

    Jan 16, 2023, 10:21 AM by
    Full story
  • Drug Discovery: Combining the Power of Computational Chemistry with Multiple Applications

    Jan 16, 2023, 10:17 AM by
    Full story
  • Alfa Chemistry Now Becomes A High-Quality 2D Material Supplier

    Jan 16, 2023, 10:16 AM by
    Full story
  • CCDC Welcomes New Applications for its FAIRE Grants to Advance Structural Science

    Jan 16, 2023, 10:15 AM by
    FAIRE grants provide access to the Cambridge Structural Database, software and training. The Frank H. Allen International Research & Education Programme (FAIRE) provides long-term grants to enable academic research in structural chemistry in over 80 eligible countries. Launched in 2017, the number of research and educational institutions with a FAIRE license nearly doubled in 2022 to 31. The initiative has supported researchers to publish over 100 scientific publications in primary research journals since its launch. With research and education organisations in over 80 countries eligible to apply, the FAIRE programme has the potential to greatly widen its positive impact and new applications are welcomed. Continued engagement with the structural science community through conferences like the Pan African Conference on Crystallography (PCCr3) currently being held in Nairobi, Kenya, aims to grow and further support the FAIRE community.
    Full story
  • «
  • 121 (current)
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy